Antidepressants are an effective treatment route for depression, novel study claims.
Researchers from Queensland University of Technology have identified a drug that could reverse the damaging effects of heavy alcohol consumption on neurogenesis.
Balovaptan, a molecule being developed by Roche for autism spectrum disorder, has been given FDA approval in order to accelerate its development.
This case report from Neurodegenerative Disease Management examines the suicide of a patient with early-onset Alzheimer’s disease in the context of planned versus impulsive acts in cognitive disorders.
In this research article from Personalized Medicine, explore how disorders such as depression and schizophrenia have been linked to specific neurotransmitter receptor variations.
In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
In this research article from Journal of Comparative Effectiveness Research, learn how differing drug treatments influence the quality of life of schizophrenia patients.
Signature patterns of electrical activity in the brain may predict impulsive behaviors, suggesting deep brain stimulation could hold potential as a treatment for several mental disorders.
A new study implicates a novel gene target in the efficacy of electroconvulsive therapy as a depression treatment.
Regions of the brain displaying increased responses to novel speech stimuli have been linked with the processing of social information and similarities drawn with schizophrenia and autism.